SEIZERT CAPITAL PARTNERS, LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 51 filers reported holding PSYCHEMEDICS CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SEIZERT CAPITAL PARTNERS, LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2019$423,000
-11.7%
30,1790.0%0.02%
-13.6%
Q4 2018$479,000
-15.7%
30,1790.0%0.02%
+4.8%
Q3 2018$568,000
+14.7%
30,179
+30.3%
0.02%
+16.7%
Q2 2018$495,0000.0%23,1640.0%0.02%0.0%
Q1 2018$495,000
-31.7%
23,164
-34.3%
0.02%
-30.8%
Q4 2017$725,000
-3.5%
35,280
-13.4%
0.03%
-7.1%
Q3 2017$751,000
+1.5%
40,755
+37.3%
0.03%
+3.7%
Q2 2017$740,00029,6780.03%
Other shareholders
PSYCHEMEDICS CORP shareholders Q2 2018
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
View complete list of PSYCHEMEDICS CORP shareholders